These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18157314)

  • 1. [The use of latex biomembrane in exenteration: case report].
    Fugimoto F; Jervásio AC; Misawa AK; Garcia R; Matayoshi S
    Arq Bras Oftalmol; 2007; 70(5):854-7. PubMed ID: 18157314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Exenteration of the Orbit for Basal Cell Carcinoma].
    Furdová A; Horkovičová K; Krčová I; Krásnik V
    Cesk Slov Oftalmol; 2015 Aug; 71(4):209-16. PubMed ID: 26395856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for orbital exenteration in periocular Basal cell carcinoma.
    Iuliano A; Strianese D; Uccello G; Diplomatico A; Tebaldi S; Bonavolontà G
    Am J Ophthalmol; 2012 Feb; 153(2):238-241.e1. PubMed ID: 21982108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtotal Exenteration of the Orbit for Benign Orbital Disease.
    Furdova A; Babal P; Zahorjanova P; Sekac J
    J Craniofac Surg; 2020; 31(5):1367-1369. PubMed ID: 32224777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supraestructure maxillectomy and orbital exenteration for treatment of basal cell carcinoma of inferior eyelid: case report and review.
    Villalon-Lopez JS; Valle-Mejia CA; Patino-Lara A; Moreno-Perez BA; Munoz-Lopez JA; Alcantar-Andrade A
    J Cancer Res Ther; 2006; 2(3):140-3. PubMed ID: 17998694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Orbital exenteration. A preventable course in tumor treatment?!].
    Schayan-Araghi K; Press UP; Hübner H
    Ophthalmologe; 1994 Aug; 91(4):536-9. PubMed ID: 7950131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The study of the use of a latex biomembrane and conjunctival autograft in rabbit conjunctiva wound healing.
    Pinho ECCM; Chahud F; Lachat JJ; Coutinho-Netto JJ; Sousa SJFE
    Arq Bras Oftalmol; 2018 Apr; 81(2):125-129. PubMed ID: 29846419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supraestructure maxillectomy and orbital exenteration for treatment of basal cell carcinoma of inferior eyelid: case report and review.
    Sebastián Villalón-López J; Arturo Valle-Mejía C; Patiño-Lara A; Moreno-Pérez Bertha A; Alejo Muñoz-López J; Alcantar-Andrade A
    J Cancer Res Ther; 2005; 1(3):132-5. PubMed ID: 17998643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orbital exenteration for invasive skin tumours.
    Tyers AG
    Eye (Lond); 2006 Oct; 20(10):1165-70. PubMed ID: 17019414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orbital hyperostosis following exenteration.
    Fleming JC; Linder JS; Karcioglu ZA
    Ophthalmic Plast Reconstr Surg; 2008; 24(5):378-82. PubMed ID: 18806659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orbital exenteration for secondary orbital tumors: a series of seven cases.
    Lin HF; Lui CC; Hsu HC; Lin SA
    Chang Gung Med J; 2002 Sep; 25(9):599-605. PubMed ID: 12479621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subconjunctival "ring" recurrence of Basal cell carcinoma of the globe.
    Lee S; Cnaan RB; Paramanathan N; Davies M; Benger R; Ghabrial R
    Ophthalmic Plast Reconstr Surg; 2010; 26(2):117-8. PubMed ID: 20305512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Orbital exenteration of tumoral origin].
    De Faria A; Alketbi M; Podeur P; Lagier J; Martel A
    J Fr Ophtalmol; 2019 Jun; 42(6):678-680. PubMed ID: 31027855
    [No Abstract]   [Full Text] [Related]  

  • 14. Mixed (nodular and morpheic) upper eyelid basal cell carcinoma with orbital invasion - histological and clinical features.
    Costan VV; Tamaş C; Dobrin N; Costache DA; Ciocoiu M
    Rom J Morphol Embryol; 2018; 59(3):977-983. PubMed ID: 30534843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orbital exenteration: a 10-year experience of a general oncology hospital.
    Soysal HG
    Orbit; 2010 Jun; 29(3):135-9. PubMed ID: 20497078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality following exenteration for malignant tumours of the orbit.
    Rahman I; Maino A; Cook AE; Leatherbarrow B
    Br J Ophthalmol; 2005 Nov; 89(11):1445-8. PubMed ID: 16234450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural-biomembrane dressing and hypersensitivity.
    Frade MA; Coutinho Netto J; Gomes FG; Mazzucato EL; Andrade TA; Foss NT
    An Bras Dermatol; 2011; 86(5):885-91. PubMed ID: 22147027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with eyelid-sparing orbital exenteration: the 2000 Tullos O. Coston Lecture.
    Shields JA; Shields CL; Demirci H; Honavar SG; Singh AD
    Ophthalmic Plast Reconstr Surg; 2001 Sep; 17(5):355-61. PubMed ID: 11642492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for orbital exenteration in periocular basal cell carcinoma.
    Shinder R
    Am J Ophthalmol; 2012 Jul; 154(1):212; author reply 212-3. PubMed ID: 22709845
    [No Abstract]   [Full Text] [Related]  

  • 20. [Eyelid reconstruction with Fricke's flap: report of two cases].
    Herzog Neto G; Sebastiá R; Viana GA; Machado F
    Arq Bras Oftalmol; 2006; 69(1):123-6. PubMed ID: 16491248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.